WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

REVIEW: BILAYER TABLET IS A NEW APPROACH

Akash N. Thorat*, Nakul P. Kathar, Dr. Gajanan S. Sanap and Manoj S. Bodkhe

ABSTRACT

In modern era bi-layer tablet is for successful development of immediate and modified drug delivery system for various diseases and disorders. Bi-layer tablets have been developed to achieve modified release of drug. Bilayer tablet is new period for the successful development of Controlled medicine Delivery System( CDDS) along with colorful features to produce a way of successful medicine delivery system. Over the once 30 times as the expenditure and complications involved in selling new medicine realities have enhanced, with attendant recognition of the remedial advantages of controlled medicine delivery, lesser attention has been concentrated on development of sustained or controlled release medicine delivery systems. Bi-layer tablets has been developed to achieve controlled delivery of different medicines withpre-defined release biographies. Bi-layer tablet is applicable for chronological release of two medicines in combination and also for sustained release of tablet in which one subcaste is for immediate release as lading cure and alternate subcaste is conservation cure. Bilayer tablets can be a primary option to avoid chemical incompatibilities between API by physical separation, and to enable the development of different medicine release biographies using DUREDAStechnology.Use ofbi-layer tablets is a veritably different aspect foranti-hypertensive, diabetic,anti-inflammatory and analgesic medicines where combination remedy is frequently used. Several pharmaceutical companies are presently developingbi-layer tablets, for a variety of reasons patent extension, remedial, marketing to name a many. This review composition provides an preface tobi-layer tablet technology, challenges inbi-layer tablet manufacturing, colorful tablet presses used, quality and GMP conditions for their product colorful ways used forbi-layer tableting and recent developments in the field ofbi-layer technology.

Keywords: Bilayer, Tablet, Microspheres, CCDS.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More